Regulatory strategy for pharma and medical devices
- Regulatory pathway + submission approach (what’s needed now vs later)
- Indication / disease / intended use fit (what is the most relevant claim)
- Evidence strategy mapped to claims (what evidence for each claim)
- Protocol + endpoints aligned to intended use (primary/secondary support claims)
- Risk-based approach to study management + documentation depth/controls
- Data integrity + traceability (audit-ready from day one)
- Site contract / legal / regulatory readiness + essential/primary documentation
- Authority/ethics interaction plan (positioning, RFIs, timelines)
- Change control & lifecycle plan (amendments / substantial modifications)
- Go/No-go decision points to avoid late redesigns